Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation

被引:13
|
作者
Hjerpe, Roland [1 ]
Aillet, Fabienne [1 ]
Lopitz-Otsoa, Fernando [1 ]
Lang, Valerie [1 ]
Torres-Ramos, Monica [1 ]
Farras, Rosa [3 ]
Hay, Ronald T. [4 ]
Rodriguez, Manuel S. [1 ,2 ]
机构
[1] CIC bioGUNE, Prote Unit, CIBERehd, Derio 48160, Bizkaia, Spain
[2] Univ Basque Country, Dept Biochem, Leioa 48940, Bizkaia, Spain
[3] Ctr Invest Principe Felipe, Valencia 46013, Spain
[4] Univ Dundee, Sch Life Sci, Interdisciplinary Res Ctr, Dundee DD1 5EH, Scotland
关键词
p53; Polyubiquitylation; Degradation; Mdm2; Proteasome; TERMINAL DOMAIN; TRANSCRIPTIONAL ACTIVITY; PROTEIN-DEGRADATION; ACTIVATE P53; IN-VIVO; UBIQUITINATION; MDM2; MULTIPLE; IDENTIFICATION; MUTATIONS;
D O I
10.1016/j.biocel.2010.01.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In normal cells p53 is maintained at low level through the action of the ubiquitin-proteasome system. As a consequence of p53 transcriptional activity, various regulators of this tumor suppressor are produced, forming a negative feedback loop tightly controlling p53 stability. One of the most prominent is the ubiquitin-ligase Mdm2. Here, we have used a transfer of signals strategy to study the p53 degradation process promoted by Mdm2 in the absence of p53 transcriptional activity. Our results show that in a p53 null background, transcriptionally silent p53-fusions require multiple N- and C-terminal signals to be optimally targeted to proteasomal degradation. As for WT p53, p53-fusions able to form tetramers are polyubiquitylated and optimally degraded by the proteasome. However, p53 molecules unable to oligomerize, show Mdm2-mediated polyubiquitylation deficiency but are still targeted to proteasome degradation in vitro and ex vivo. In the presence of Mdm2, nuclear shuttling of p53 monomeric fusions favours proteasome-dependent degradability but not its polyubiquitylation. In vitro, 265 proteasome fails to drive degradation of OD mutants in the presence of Mdm2, suggesting the contribution of additional cellular factors in this process. All together, our results indicate that Mdm2-mediated proteasome-dependent degradation of polyubiquitylation deficient p53 monomers is mechanistically possible, taking alternative pathways to better achieve their proteolysis. These results support the existence of additional levels to regulate p53 stability and activity acting on individual subunits of the functional tetramer. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:725 / 735
页数:11
相关论文
共 50 条
  • [11] Proteasome activator PA28γ regulates p53 by enhancing its MDM2-mediated degradation
    Zhang, Zhuo
    Zhang, Ruiwen
    EMBO JOURNAL, 2008, 27 (06) : 852 - 864
  • [12] Butein activates p53 in hepatocellular carcinoma cells via blocking MDM2-mediated ubiquitination
    Zhou, Yuanfeng
    Wang, Kuifeng
    Zhou, Ni
    Huang, Tingting
    Zhu, Jiansheng
    Li, Jicheng
    ONCOTARGETS AND THERAPY, 2018, 11 : 2007 - 2015
  • [13] HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53
    Wang, Yuhong
    Hu, Lin
    Wang, Jian
    Li, Xiangwei
    Sahengbieke, Sana
    Wu, Jingjing
    Lai, Maode
    JOURNAL OF PATHOLOGY, 2018, 246 (04) : 508 - 518
  • [14] MDM2-Mediated p21 Proteasomal Degradation Promotes Fluoride Toxicity in Ameloblasts
    Deng, Huidan
    Ikeda, Atsushi
    Cui, Hengmin
    Bartlett, John D.
    Suzuki, Maiko
    CELLS, 2019, 8 (05)
  • [15] Ubiquitin proteasomal pathway mediated degradation of p53 in melanoma
    Anwar, Adil
    Norris, David A.
    Fujita, Mayumi
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2011, 508 (02) : 198 - 203
  • [16] The Elephant Evolved p53 Isoforms that Escape MDM2-Mediated Repression and Cancer
    Padariya, Monikaben
    Jooste, Mia-Lyn
    Hupp, Ted
    Fahraeus, Robin
    Vojtesek, Borek
    Vollrath, Fritz
    Kalathiya, Umesh
    Karakostis, Konstantinos
    MOLECULAR BIOLOGY AND EVOLUTION, 2022, 39 (07)
  • [17] Lactamase β reprograms lipid metabolism to inhibit the progression of endometrial cancer through attenuating MDM2-mediated p53 ubiquitination and degradation
    Zhou, Ting
    Li, Xiaorong
    Zhao, Fangfang
    Zhou, Jing
    Sun, Binghui
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2025, 764
  • [18] A novel Aurora-A-mediated phosphorylation of p53 inhibits its interaction with MDM2
    Hsueh, Kai-Wei
    Fu, Shu-Ling
    Chang, Chirn-Bin
    Chang, Yu-Ling
    Lin, Chao-Hsiung
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2013, 1834 (02): : 508 - 515
  • [19] Ubiquitin receptors play redundant roles in the proteasomal degradation of the p53 repressor MDM2
    Sparks, Alison
    Kelly, Christopher J.
    Saville, Mark K.
    FEBS LETTERS, 2022, 596 (21) : 2746 - 2767
  • [20] The p53 isoforms are differentially modified by Mdm2
    Camus, Suzanne
    Menendez, Sergio
    Fernandes, Kenneth
    Kua, Nelly
    Liu, Geng
    Xirodimas, Dimitris P.
    Lane, David P.
    Bourdon, Jean-Christophe
    CELL CYCLE, 2012, 11 (08) : 1646 - 1655